JP2023546112A5 - - Google Patents

Info

Publication number
JP2023546112A5
JP2023546112A5 JP2023523019A JP2023523019A JP2023546112A5 JP 2023546112 A5 JP2023546112 A5 JP 2023546112A5 JP 2023523019 A JP2023523019 A JP 2023523019A JP 2023523019 A JP2023523019 A JP 2023523019A JP 2023546112 A5 JP2023546112 A5 JP 2023546112A5
Authority
JP
Japan
Application number
JP2023523019A
Other languages
Japanese (ja)
Other versions
JP2023546112A (ja
JPWO2022079161A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/078433 external-priority patent/WO2022079161A1/en
Publication of JP2023546112A publication Critical patent/JP2023546112A/ja
Publication of JPWO2022079161A5 publication Critical patent/JPWO2022079161A5/ja
Publication of JP2023546112A5 publication Critical patent/JP2023546112A5/ja
Pending legal-status Critical Current

Links

JP2023523019A 2020-10-15 2021-10-14 長時間作用型眼送達用非共有結合タンパク質-ヒアルロナンコンジュゲート Pending JP2023546112A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063092251P 2020-10-15 2020-10-15
US63/092,251 2020-10-15
US202163250782P 2021-09-30 2021-09-30
US63/250,782 2021-09-30
PCT/EP2021/078433 WO2022079161A1 (en) 2020-10-15 2021-10-14 Non-covalent protein-hyaluronan conjugates for long-acting ocular delivery

Publications (3)

Publication Number Publication Date
JP2023546112A JP2023546112A (ja) 2023-11-01
JPWO2022079161A5 JPWO2022079161A5 (https=) 2024-10-23
JP2023546112A5 true JP2023546112A5 (https=) 2024-10-23

Family

ID=78483243

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2023523019A Pending JP2023546112A (ja) 2020-10-15 2021-10-14 長時間作用型眼送達用非共有結合タンパク質-ヒアルロナンコンジュゲート
JP2023523034A Pending JP2023545514A (ja) 2020-10-15 2021-10-14 治療薬の長時間作用型送達のためのバーシカン(vg1)のヒアルロン酸結合誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023523034A Pending JP2023545514A (ja) 2020-10-15 2021-10-14 治療薬の長時間作用型送達のためのバーシカン(vg1)のヒアルロン酸結合誘導体

Country Status (10)

Country Link
US (2) US20230279090A1 (https=)
EP (2) EP4228706A1 (https=)
JP (2) JP2023546112A (https=)
KR (2) KR20230088743A (https=)
CN (1) CN116390767A (https=)
AU (2) AU2021360935A1 (https=)
CA (2) CA3198668A1 (https=)
IL (2) IL302087A (https=)
TW (2) TW202228790A (https=)
WO (2) WO2022079161A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118718181A (zh) 2019-06-05 2024-10-01 里珍纳龙药品有限公司 用于精确剂量递送的装置及方法
USD1120314S1 (en) 2022-11-30 2026-03-24 Regeneron Pharmaceuticals, Inc. Dose delivery device
WO2025242919A1 (en) * 2024-05-24 2025-11-27 Navigo Proteins Gmbh Novel binding proteins for hyaluronic acid
WO2026022392A1 (en) * 2024-07-26 2026-01-29 Ospedale San Raffaele S.R.L. Peptide and conjugates thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5144088A (en) 1991-04-26 1992-09-01 Aristech Chemical Corporation Manufacture of neopentyl glycol (I)
JP3957765B2 (ja) 1997-04-07 2007-08-15 ジェネンテク・インコーポレイテッド 抗vegf抗体
DE60140474D1 (de) 2000-09-08 2009-12-24 Univ Zuerich Sammlung von proteinen mit sich wiederholenden sequenzen (repeat proteins), die repetitive sequenzmodule enthalten
US7771742B2 (en) 2004-04-30 2010-08-10 Allergan, Inc. Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
LT3216803T (lt) 2008-06-25 2020-06-10 Novartis Ag Stabilūs ir tirpūs antikūnai, slopinantys vegf
US20140248296A1 (en) * 2008-10-16 2014-09-04 Kathleen Cogan Farinas Sustained drug delivery system
US8133979B2 (en) 2008-12-16 2012-03-13 Hoffmann-La Roche Inc. Antibodies against human angiopoietin 2
LT3495387T (lt) 2012-07-13 2021-11-25 Roche Glycart Ag Bispecifiniai anti-vegf / anti-ang-2 antikūnai ir jų panaudojimas akių kraujagyslių ligoms gydyti
EP2935589A1 (en) 2012-12-18 2015-10-28 Novartis AG Compositions and methods that utilize a peptide tag that binds to hyaluronan
US10434188B1 (en) * 2013-06-04 2019-10-08 The Trustees Of Indiana University Hyaluronic acid binding domain-growth factor fusion protein cDNAs and fusion proteins for cartilage matrix preservation and repair
CN105008791B (zh) 2013-08-06 2017-08-29 奥林巴斯株式会社 光源光学系统、光纤光源、显微镜和汽车用前照灯
WO2015198243A2 (en) 2014-06-25 2015-12-30 Novartis Ag Compositions and methods for long acting proteins
WO2016073157A1 (en) 2014-11-06 2016-05-12 Genentech, Inc. Anti-ang2 antibodies and methods of use thereof
PT3215530T (pt) 2014-11-07 2019-11-21 Sesen Bio Inc Anticorpos de il-6 melhorados
CA3012718A1 (en) * 2016-02-08 2017-08-17 Vitrisa Therapeutics, Inc. Compositions with improved intravitreal half-life and uses thereof

Similar Documents

Publication Publication Date Title
JP2023545514A5 (https=)
JP2023546112A5 (https=)
CN305605382S (https=)
CN305617717S (https=)
CN305758103S (https=)
CN305725433S (https=)
CN305710742S (https=)
CN305703844S (https=)
CN305699038S (https=)
CN305698525S (https=)
CN305697824S (https=)
CN305528611S (https=)
CN305603001S (https=)
CN305760362S (https=)
CN305536815S (https=)
CN306164042S (https=)
CN305536155S (https=)
CN305534600S (https=)
CN305616833S (https=)
CN305605937S (https=)
CN305533975S (https=)
CN305532610S (https=)
CN305531116S (https=)
CN305529249S (https=)
CN305758968S (https=)